fig6
From: Reprogrammed lipid metabolism in advanced resistant cancers: an upcoming therapeutic opportunity
Figure 6. CD36 is a crucial target in aggressive and resistant tumors. A simplified representation showing that high levels of CD36 are correlated with malignancy, poor prognosis, and resistance to therapy in several cancers. CD36 is a FA transporter. FA: Fatty acid; SCC: squamous cell carcinoma; PD-1: programmed cell death protein 1.
